Arbutus Biopharma Corporation
ABUS
$4.58
$0.173.86%
NASDAQ
| 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | 95.23M | 91.47M | 93.70M | 98.09M | 112.71M |
| Total Receivables | 180.45M | 1.75M | 1.21M | 1.13M | 1.38M |
| Inventory | -- | -- | -- | -- | -- |
| Prepaid Expenses | 1.33M | 1.24M | 2.54M | 3.91M | 2.72M |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | -- | -- | -- | -- | -- |
| Total Current Assets | 277.01M | 94.46M | 97.44M | 103.12M | 116.81M |
|
|
|||||
| Total Current Assets | 277.01M | 94.46M | 97.44M | 103.12M | 116.81M |
| Net Property, Plant & Equipment | 22.00K | 32.00K | 137.00K | 148.00K | 168.00K |
| Long-term Investments | -- | -- | -- | -- | -- |
| Goodwill | -- | -- | -- | -- | -- |
| Total Other Intangibles | -- | -- | -- | -- | -- |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | 131.00K | 130.00K | 131.00K | -- | 34.00K |
| Total Assets | 277.16M | 94.62M | 97.71M | 103.27M | 117.01M |
|
|
|||||
| Total Accounts Payable | 1.46M | 1.17M | 1.01M | 1.32M | 2.24M |
| Total Accrued Expenses | 2.77M | 3.65M | 2.88M | 2.42M | 3.90M |
| Short-term Debt | -- | -- | -- | -- | -- |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | 631.00K | 547.00K | 531.00K | 514.00K | 563.00K |
| Total Finance Division Other Current Liabilities | 245.00K | 640.00K | 763.00K | 768.00K | 12.72M |
| Total Other Current Liabilities | 245.00K | 640.00K | 763.00K | 768.00K | 12.72M |
| Total Current Liabilities | 5.11M | 6.01M | 5.18M | 5.02M | 19.43M |
|
|
|||||
| Total Current Liabilities | 5.11M | 6.01M | 5.18M | 5.02M | 19.43M |
| Long-Term Debt | 3.28M | 3.44M | 3.68M | 3.91M | 4.41M |
| Short-term Debt | -- | -- | -- | -- | -- |
| Capital Leases | -- | 199.00K | 391.00K | 575.00K | 626.00K |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | 8.60M | 8.40M | 11.05M | 10.78M | 13.39M |
| Total Liabilities | 16.99M | 18.04M | 20.31M | 20.29M | 37.85M |
|
|
|||||
| Common Stock & APIC | 1.52B | 1.50B | 1.50B | 1.50B | 1.50B |
| Retained Earnings | -1.21B | -1.38B | -1.38B | -1.37B | -1.37B |
| Treasury Stock & Other | -48.20M | -48.10M | -48.13M | -48.19M | -48.17M |
| Total Common Equity | 260.18M | 76.58M | 77.40M | 82.98M | 79.16M |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | -- | -- | -- | -- | -- |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | -- | -- | -- | -- | -- |
|
|
|||||
| Total Common Equity | 260.18M | 76.58M | 77.40M | 82.98M | 79.16M |
| Total Preferred Equity | -- | -- | -- | -- | -- |
| Total Minority Interest | -- | -- | -- | -- | -- |
| Total Equity | 260.18M | 76.58M | 77.40M | 82.98M | 79.16M |
|
|
|||||